{"doi":"10.1016/j.biochi.2017.01.001","title":"Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1","abstract":null,"journal":"Biochimie","year":2017,"id":631480,"datarank":0.3958585994422889,"base_score":2.639057329615259,"endowment":2.639057329615259,"self_citation_contribution":0.3958585994422889,"citation_network_contribution":0.0,"self_endowment_contribution":0.3958585994422889,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":13,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1636495,"name":"Dina S. Stepanova","orcid":null,"position":1,"is_corresponding":false},{"id":1571730,"name":"Sergey M. Deyev","orcid":null,"position":2,"is_corresponding":false},{"id":343747,"name":"Jonathan Chernoff","orcid":"0000-0002-4803-7836","position":3,"is_corresponding":false},{"id":257410,"name":"Galina Semenova","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1","abstract":"The variable manifestation of phenotypes that occur in patients with neurofibromatosis type 1 (NF1) includes benign and malignant neurocutaneous tumors for which no adequate treatment exists. Cell-based screening of known bioactive compounds library identified the protein phosphatase 2A (PP2A) inhibitor Cantharidin and the L-type calcium channel blocker Nifedipine as potential candidates for NF1 pharmacotherapy. Validation of screening results using human NF1-associated malignant peripheral nerve sheath tumor (MPNST) cells showed that Cantharidin effectively impeded MPNST cell growth, while Nifedipine treatment significantly decreased local tumor growth in an MPNST xenograft animal model. These data suggest that inhibitors of PP2A, as well as calcium channel blockers, might be used in broader MPNST preclinical studies as single agents or in combinatorial therapeutic strategies.","is_dataset_classified":null,"base_score":2.639057329615259,"endowment":2.639057329615259,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"28065690","pmcid":"PMC5405558","openalex_id":"https://openalex.org/W2570520267","authors":[],"funders":[{"funder_name":"NIH","grant_id":"RO1 CA142928","title":null},{"funder_name":"Children's Tumor Foundation","grant_id":"2011-15-012","title":null},{"funder_name":"NIH CORE","grant_id":"P30 CA006927","title":null},{"funder_name":"RSF","grant_id":"14-24-00106","title":null},{"funder_name":"NCI NIH HHS","grant_id":"R01 CA098830","title":null},{"funder_name":"NCI NIH HHS","grant_id":"R01 CA148805","title":null},{"funder_name":"NCI NIH HHS","grant_id":"R01 CA142928","title":null}],"total_grants":7,"fwci":0.3971,"citation_percentile":0.5338343,"influential_citations":0,"citation_trend":[{"year":2017,"count":2},{"year":2019,"count":1},{"year":2020,"count":2},{"year":2021,"count":2},{"year":2022,"count":2},{"year":2024,"count":1},{"year":2025,"count":2},{"year":2026,"count":1}],"oa_status":"green","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5405558","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5405558","host_type":"repository"},{"url":"https://api.elsevier.com/content/article/PII:S0300908417300019?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0300908417300019?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.biochi.2017.01.001","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/28065690","host_type":"repository"}],"fields_of_study":["Beetle Biology and Toxicology Studies","Neurofibromatosis and Schwannoma Cases","Advanced Synthetic Organic Chemistry"],"mesh_terms":["Animals","Calcium Channel Blockers","Cantharidin","Cell Line","Female","Fibroblasts","Mice, Nude","Neurofibromatosis 1","Nifedipine","Gene Expression Regulation, Neoplastic","Apoptosis","Nerve Sheath Neoplasms","Xenograft Model Antitumor Assays","Cell Line, Tumor","Cell Proliferation","Mice","Protein Phosphatase 2"],"keywords":["Cantharidin","Neurofibromatosis","Calcium channel","Cancer research","Merlin (protein)","Nifedipine","Pharmacotherapy","Pharmacology","Medicine","Chemistry","Calcium","Internal medicine","Pathology","Cancer","Chemical screening","Neurofibromatosis Type 1"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-05T23:43:45.089786Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}